Developing Bacterial Metabolites for Therapeutics

Adapsyn Bioscience is a Canadian chemical bioinformatics company focused on the discovery and development of novel small molecule therapeutics. Adapsyn’s platform analyses metabolomic and genomic data from bacteria to identify, isolate, characterize, and test novel druglike molecules, and Adapsyn has established the capability to screen thousands of compounds per year. The technology can be applied to find new drugs in the fields of oncology; bacterial, fungal, and viral infection; autoimmune disorders; cardiovascular and lipid metabolism disorders; neuroscience; and others.